5 Best Logistics Stocks To Invest In 2015

5 Best Logistics Stocks To Invest In 2015: PDL BioPharma Inc.(PDLI)

PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Advisors' Opinion:

• [By Eric Volkman]

  PDL BioPharma (NASDAQ: PDLI  ) is expecting a healthy bump in its royalty revenue for the current quarter, which ends on June 30. The company has issued guidance for the period, estimating that it will take in royalty revenue of around $143 million. That would represent a 13% increase over the Q2 2012 figure of $126 million.

• [By John Udovich]

  Small cap patent stocks Spherix Inc (NASDAQ: SPEX), PDL BioPharma Inc (NASDAQ: PDLI) and Endeavor IP Inc (OTCBB: ENIP) are among thegrowing number of publicly tradedUS entities focused on collecting and making money from various types of patents. After all, monetizing patents can lead to incredible returns. For example: Nomura analyst Rick Sherlund wrote in a research note back in November that Microsoft Corporation (NASDAQ: MSFT) is generating $2 billion per year in revenue from Android patent royalties and heestimates that this revenue has a 95% margin. However, there are risks associated with investing in stocks that invest in patents because a bi-partisan bill called the Innovation Act (H.R. 3309) isworking its way through Congress to try and reign in the activities of so-called"patent trolls" or rather c! ompanies that buy or license patents from others.

• [By Brian Orelli]

  PDL BioPharma (NASDAQ: PDLI  ) did much better with the spin out of its development stage program into Facet Biotech. The biotech started trading at $13per share, and was eventually taken out by Abbott for $27. The main assets now reside in Abbott's aforementioned spinout AbbVie in conjunction with Biogen Idec, which was developing the drugs with PDL. If the drugs are successful, maybe the duo will spin them out into a joint venture, completing the cycle?

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/5-best-logistics-stocks-to-invest-in-2015-2.html